Journal of Tuberculosis and Therapeutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Opinion Article   
  • J Tuberc Ther 2018, Vol 3(3): 117

Pharmacogenomic based miRNA Regulation in Tuberculosis: An Initiation towards the Discovery of Systemic Biomarkers to Treat Tuberculosis in Future

Harishchander Anandaram*
Department of Bioinformatics, Sathyabama University, Chennai, India
*Corresponding Author : Harishchander Anandaram, Department of Bioinformatics, Sathyabama University, Chennai, India, Tel: +919940066227, Email: harishchander.a@gmail.com

Received Date: Jun 11, 2018 / Accepted Date: Jul 03, 2018 / Published Date: Jul 10, 2018

Citation: Anandaram H (2018) Pharmacogenomic based miRNA Regulation in Tuberculosis: An Initiation towards the Discovery of Systemic Biomarkers to Treat Tuberculosis in Future. J Tuberc Ther 3: 117.

Copyright: © 2018 Anandaram H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top